Most executives treat AI like a magic wand they can wave over a stagnant P&L to conjure growth. It does not work that way. Real-world utility in manufacturing and drug discovery comes from a cold, hard look at where your process is actually breaking. If you buy a tool before you find the friction, you are just paying for a digital paperweight.
The Prerequisites: What You'll Need
- A comprehensive bottleneck map identifying exactly where production or research slows down.
- Baseline performance metrics (e.g., current engineering hours spent on repetitive tasks).
- A supply chain audit to ensure raw materials meet sustainability standards, such as FSC certification.
- A technical team capable of distinguishing between a generic LLM and specialized models like NeuralPLexer or Enchant.
Before you write a single check to a vendor, you must determine if your problem is a technology problem or a process problem. Applying AI to a broken process only makes the mistakes happen faster.
The Operational Integration Process
- Identify the Constraint: Stop asking how to adopt AI. Instead, ask where you are constrained. For example, PP Control & Automation ignored the hype and focused on operational constraints first.
- Select the Specific Tool: Match the technology to the friction. If quality inspection is the bottleneck, look at acoustic AI solutions like Deeply, which recently placed in the top 10 of SKF's Industry of the Future Challenge 2026.
- Integrate into the Workflow: Deploy the tool where it removes the most friction. Tokyo Electron did this by integrating AI into the entire semiconductor workflow, from equipment design to process development via their Epsira concept.
- Verify the Chain of Custody: Ensure your automation does not compromise your ethics. Follow the example of Playdale Playgrounds, which secured FSC Chain of Custody Certification (FSC C227343) to ensure a transparent, verified supply chain.
- Measure the Recovery: Calculate the actual capacity regained. PP Control & Automation used this method to recover 36% of their engineering capacity.
"For organisations looking to move from experimentation to impact, the starting question should not be ‘how do we adopt AI’ instead it should be ‘where are we constrained, and what is the most effective way to remove that constraint?’"— Ian Knight, CIO of PP Control & Automation
Real-World Result
The 36% Benchmark: When PP Control & Automation focused on bottlenecks rather than AI trends, they didn't just 'improve'—they recovered over a third of their engineering capacity. That is the difference between a trend and a tool.
Once the internal bottlenecks are cleared, the focus should move to external partnerships that provide specialized capabilities you cannot build in-house.
| Industry | Specific AI Application | Strategic Outcome |
|---|---|---|
| Pharmaceuticals | Enchant and NeuralPLexer models | Identification of novel small molecules (Bayer/Iambic) |
| Semiconductors | Epsira DX solutions | Optimization of 3DI manufacturing (Tokyo Electron) |
| Industrial Parts | Acoustic AI (Listen AI) | Automated quality inspection (Deeply/SKF) |
Common Pitfalls to Avoid
- Adopting AI for the sake of the press release: This leads to expensive tools that solve problems no one actually has.
- Ignoring the 'Dirty' Data: AI is useless if your supply chain is opaque. Certification (like FSC) must precede automation.
- Over-reliance on Generalists: Using a general AI for drug discovery instead of targeted platforms like Iambic’s specialized models.
- Emotional Trading: In financial markets, retail investors often fail because they use bots to chase trends rather than using them to reduce emotional decision-making.
Capacity Recovery vs. Implementation Strategy
Executive Insight
+18.4%
YTD Growth